A Study to Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Anti-Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in Korea
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Janssen Korea, Ltd., Korea
Age
20–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosed with RA
Visiting a medical internist in a study site during the study period on out patient basis
Clareo Health | A Study to Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Anti-Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in Korea
